Heterogeneous loss of the Y chromosome in leukocyte lineages of donor origin after stem cell transplantation [2]

Bone Marrow Transplantation

Volumn 38, Issue 6, 2006, Pages 463-465

  Buno I ^a   Kwon, M ^a   Balsalobre, P ^a   Serrano, D ^a   Carrion R ^a   Gomez Pineda A ^a   Diez Martin J L ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; STEROID; THIOTEPA; THYMOCYTE ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER MORTALITY; CASE REPORT; CAUSE OF DEATH; CD34 SELECTION; CELL LINEAGE; CHIMERA; CHROMOSOME LOSS; DONOR; DRUG MEGADOSE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HLA TYPING; HUMAN; IMMUNOMAGNETIC SEPARATION; IMMUNOSUPPRESSIVE TREATMENT; LETTER; LEUKEMIA RELAPSE; LEUKOCYTE; MYELOABLATIVE CONDITIONING; PHENOTYPE; PRIORITY JOURNAL; SEPSIS; STEM CELL TRANSPLANTATION; T CELL DEPLETION; TURNER SYNDROME; Y CHROMOSOME;

ADULT; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, Y; FEMALE; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; STEM CELL TRANSPLANTATION; TISSUE DONORS; TRANSPLANTATION CHIMERA; TRANSPLANTATION, HOMOLOGOUS;

EID: 33748420645     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705470     Document Type: Letter

References (14)

1. United Kingdom Cancer Cytogenetics Group. Loss of the Y chromosome from normal and neoplastic bone marrows. United Kingdom Cancer Cytogenetics Group (UKCCG). Genes Chromosomes Cancer 1992; 5: 83-88.
2. Wiktor A, Rybicki BA, Piao ZS, Shurafa M, Barthel B, Maeda K et al. Clinical significance of Y chromosome loss in hematologic disease. Genes Chromosomes Cancer 2000; 27: 11-16.
3. Pierre RV, Hoagland HC. Age-associated aneuploidy: Loss of Y chromosome from human bone marrow cells with aging. Cancer 1972; 30: 889-894.
4. Buño I, Anta B, Moreno-López E, Balsalobre P, Balas A, García-Sánchez F et al. Lineage-specific chimaerism quantification after T-cell depleted peripheral blood stem cell transplantation. Leuk Lymphoma 2003; 44: 659-667.
5. al-Attas RA, Rahi AH, Ahmed el-FE. Common variable immunodeficiency with CD4 + T lymphocytopenia and over-production of soluble IL-2 receptor associated with Turner's syndrome and dorsal kyphoscoliosis. J Clin Pathol 1997; 50: 876-879.
6. Cacciari E, Masi M, Fantini MP, Licastro F, Cicognani A, Pirazzoli P et al. Serum immunoglobulins and lymphocyte subpopulations derangement in Turner's syndrome. J Immunogenet 1981; 8: 337-344.
7. Mock B, Markert UR, Vogelsang H, Jager L. Selective T-cell deficiency in Turner's syndrome. J Investig Allergol Clin Immunol 2000; 10: 312-313.
8. Gupta S, Chiplunkar S, Gupta A, Gollapudi S. Increased spontaneous, tumor necrosis factor receptor- and CD95 (Fas)-mediated apoptosis in cord blood T-cell subsets from Turner's syndrome. Genes Immun 2003; 4: 239-243.
9. Hochberg Z, Aviram M, Rubin D, Pollack S. Decreased sensitivity to insulin-like growth factor I in Turner's syndrome: A study of monocytes and T lymphocytes. Eur J Clin Invest 1997; 27: 543-547.
10. Zinn AR, Ross JL. Turner syndrome and haploinsufficiency. Curr Opin Genet Dev 1998; 8: 322-327.
11. Lahn BT, Page DC. Functional coherence of the human Y chromosome. Science 1997; 278: 675-680.
12. Quintana-Murci L, Krausz C, McElreavey K. The human Y chromosome: function, evolution and disease. Forensic Sci Int 2001; 118: 169-181.
13. Vogt PH, Affara N, Davey P, Hammer M, Jobling MA, Lau YF et al. Report of the Third International Workshop on Y Chromosome Mapping 1997. Cytogenet Cell Genet 1997; 79: 1-20.
14. Skaletsky H, Kuroda-Kawaguchi T, Minx PJ, Cordum HS, Hillier L, Brown LG et al. The male-specific region of the human Y chromosome is a mosaic of discrete sequence classes. Nature 2003; 423: 825-837.